Who has invested in Seraxis?

Eli Lilly are named among the investors backing Seraxis.

Seraxis Funding: $40M Raised, Series C (2025)

Seraxis funding overview

Seraxis is based in Germantown, MD. Seraxis has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in July 2025. The round record for Seraxis runs through 2025; nothing later has been disclosed. Investors on record include Eli Lilly.

Seraxis at a glance

Total raised: $40M
Latest round: Series C
Latest round date: July 2025
Headquarters: Germantown, MD
Notable investors: Eli Lilly

Frequently asked about Seraxis funding

How much has Seraxis raised?: Seraxis has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Seraxis?: Eli Lilly are named among the investors backing Seraxis.
What was the latest Seraxis funding round?: The most recent disclosed round is a Series C, announced in July 2025.
Where is Seraxis based?: Seraxis is based in Germantown, MD.
When did Seraxis last raise?: The last disclosed Seraxis round closed in July 2025 at Series C.

Totals shown for Seraxis aggregate every disclosed round on file. To see how that compares, browse the companies in Germantown and the investors behind them below.

Seraxis Funding: $40M Raised, Series C (2025)

Seraxis funding overview

Seraxis at a glance

Frequently asked about Seraxis funding

Companies related to Seraxis (17)

Browse related funding lists (4)